Xenter Secures $58.3 Million in Latest Series B Funding Round

Xenter secured $58.3 million in its latest Series B, adding another data point to the Enterprise Software & SaaS funding market.

Xenter Raises $58.3 million in Funding

Xenter Raises $58.25 Million Series B To Accelerate TechMed Platform Commercialization. Xenter said the investors share its vision of transforming how clinical data is captured, connected and used across hospitals and physicians’ offices.

Investors Behind the Funding

The round was backed by existing shareholders. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Xenter operates in Enterprise Software & SaaS. Xenter's financing adds to recent private-market activity.

Strategic Use of Funds

Accelerate TechMed Platform Commercialization

Looking Ahead

said Richard J. Linder, Founder, Chairman and Chief Executive Officer of Xnter.

Source reference: original announcement/article.